Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03599453
Brief Title: Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

First Submitted : July 16, 2018
First Submitted that Met QC Criteria : July 16, 2018
First Posted : July 25, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : October 3, 2019
Last Update Posted : October 7, 2019